(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s vote in the Energy and Commerce Subcommittee on Health on the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act:
PCMA Launches New Campaign Aimed at Repealing the Medicare Prescription Drug Rebate Rule March 1, 2021 ARTICLE (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) unveiled a new campaign commending the Biden Administration for delaying the Medicare prescription drug
A new book from the University of Pennsylvania Wharton School professor Lawton Robert Burns examines pharmacy benefit companies and describes their critical role in the prescription drug supply chain. Burns concludes that PBMs are intermediaries using tools to control healthcare
In case you missed it, Ike Brannon, senior fellow at the Jack Kemp Foundation and former senior economist for the United States Treasury and U.S. Congress, explains the problem with misguided policies targeting pharmacy benefit companies in a new RealClearMarkets
Executive Vice President, CVS Health President, CVS Caremark Alan Lotvin, M.D., is executive vice president of CVS Health, and president of CVS Caremark, the company’s pharmacy benefits management (PBM) business. In this role, Dr. Lotvin oversees all aspects of the
Dr. Lawton Burns Says PBMs are Unfairly Blamed for High Drug Prices, Should Look At Big Drug Companies In case you missed it, Lawton R. Burns, PhD, professor of health care management at the Wharton School of the University of
©2024 PCMA. All Rights Reserved.
